What is Sepax Technologies?
Sepax Technologies, Inc. operates at the intersection of advanced material science and life sciences, specializing in high-performance chromatographic solutions. The company provides a robust portfolio of products, including SEC-MALS systems, specialized resins, and precision purification columns. Their technical expertise enables biopharmaceutical and biotechnology organizations to streamline the purification and analysis of complex biomolecules, such as antibodies, antibody-drug conjugates (ADCs), and proteins. By offering both analytical chromatography and custom resin development, Sepax serves as a vital partner for research and development teams aiming to improve yield and purity in therapeutic manufacturing.
How much funding has Sepax Technologies raised?
Sepax Technologies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Sepax Technologies
PPP
Public-Private Partnership
What's next for Sepax Technologies?
With this late-stage capital, Sepax Technologies is expected to prioritize the expansion of its manufacturing capabilities and the diversification of its product pipeline. The strategic focus will likely shift toward scaling production to meet the growing demand for high-purity separation tools in the global biotech sector. Furthermore, the company is poised to invest in technical resources that support the increasingly complex requirements of protein purification, ensuring they remain at the forefront of the life sciences industry. This growth trajectory suggests a move toward broader market penetration and the potential for further innovation in automated purification workflows.
See full Sepax Technologies company page
